Low molecular weight heparin (LMWH) is a class of anticoagulant medications derived from standard heparin. It is commonly used to prevent and treat blood clots. LMWH has a more predictable pharmacokinetic profile, longer half-life, and less frequent dosing compared to unfractionated heparin.